Physicians for Reproductive Health Files Amicus Brief Opposing Texas District Court’s Ruling on Medication Abortion
Press releases | April 12, 2023
Fried Frank filed an amicus brief in the US Court of Appeals for the Fifth Circuit on behalf of Physicians for Reproductive Health (PRH), a physician-led national advocacy organization that organizes, mobilizes and amplifies the voices of medical providers to advance sexual and reproductive health, rights and justice. The brief advocates for a stay of Judge Matthew Kacsmaryk’s order attempting to void the US Food and Drug Administration’s approval of mifepristone, a drug used in medication abortion.
The brief presents the real-world experiences of physicians who counsel and care for patients at all stages of pregnancy and focuses on the use of mifepristone to manage miscarriages and late-term fetal demise. Specifically, doctors in the PRH network assert that mifepristone has provided patients with privacy, dignity and autonomy and has reduced risks of complications and the need for secondary procedures. The brief confirms that physicians have confidently prescribed mifepristone for two decades and have determined that it is safe, effective and beneficial to patients. The brief highlights the additional challenges physicians anticipate if mifepristone is taken off the market.
The brief states, “eliminating access to mifepristone will hurt patients by eliminating their ability to choose treatment that is medically sound, and will jeopardize patient health.”
“Many of PRH’s providers prescribe and administer mifepristone on a regular basis. As experienced medical professionals with training in obstetrics, gynecology and complex family planning specialties, these providers are in the unique position to offer first-hand perspectives and experiences on the safety and efficacy of mifepristone, how providers share information and obtain informed consent from patients electing a course of treatment involving mifepristone, why access to mifepristone is critical and the ways that limiting access to mifepristone would disrupt the standard medical practice nationwide.”
The full brief is available here.
The Fried Frank team was led by partner Janice Mac Avoy and special counsel Laura Israel Sinrod and included associates Anne Aufhauser, Dylan B. Bolduc and Alexis Casamassima and law clerk Lucretia Bunzel.
Fried Frank prepared the brief in partnership with the Center for Reproductive Rights, a global legal advocacy organization that seeks to advance reproductive rights, such as abortion.
This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.